How to choose between serpatinib and pralsetinib

Pralsetinib (Pralsetinib) and serpatinib are drugs used to treat a type of lung and thyroid cancer with a rearrangement of the gene called RET. Before choosing either of these drugs, doctors often perform genetic testing to detect whether patients have RET gene rearrangements. If the genetic test results are positive, indicating that a RET gene rearrangement is present, these two drugs may be appropriate options. Serpatinib and platinib are approved for different types and stages of RET gene-rearranged lung and thyroid cancer. Patients need to ensure that they choose the correct drug according to the type and stage of the tumor before use.